|
Program
|
Monday, November 2
| 6:30 am – 6:00 pm |
Registration |
| 6:45 – 7:45 am |
Early Morning Workshops |
| 8:00 – 9:30 am |
Presidential Plenary I |
| 8:00 am – 5:30 pm |
Poster Session III (presentation time 1:00 – 2:30pm) |
| 9:30 – 10:00 am |
Award Presentations (DAA and DSA) |
| 9:30 am – 3:00 pm |
Exhibits Open |
| 10:00 – 10:30 am |
Hyman J Zimmerman Hepatoxicity State-of-the-Art Lecture: Bioartificial Livers and Their Potential Use in Drug Toxicity Screening |
| 11:00 am – 12:30 pm |
Presidential Plenary II |
| 11:00 am – 12:30 pm |
Advances for Practitioners |
| 3:00 – 4:30 pm |
Parallel Sessions |
| 3:00 – 4:30 pm |
General Hepatology Update II: Management of Hepatic Encephalopathy; Alcoholic Liver Disease; Acute Liver Failure |
|
Moderators: Gregory J. Gores, MD and Andrea Ewing Reid, MD |
| 3:00 – 4:30 pm |
Global HCC Update (AASLD/EASL/APASL): International Management Strategies for HCC in Patients with Advanced Liver Disease |
| 3:00 – 5:00 pm |
AASLD/CDC Corner |
| 4:45 – 6:15 pm |
Late-breaking Abstracts |
| 4:45 – 6:15 pm |
Parallel Sessions |
| 5:00 – 6:30 pm |
Practice Management Workshop |
|
Moderator: Vinod K. Rustgi, MD |
| 6:30 pm |
Industry-supported Satellite Symposia |
| 7:00 – 10:00 pm |
Focused Study Groups
1. Primary Prophylaxis of Variceal Hemorrhage in Children: Can We Really Do a Randomized Trial?
Moderators: Simon C. Ling, MBChB, MRCP and Kathleen B. Schwarz, MD
2. Cellular Targets of Lipotoxicity in NAFLD
Moderators: Gyorgy Baffy, MD, PhD; Stephen H. Caldwell, MD; and Stephen A. Harrison, MD
|
| 7:00 – 10:00 pm |
Mini-symposia
1. Diagnosis and Treatment of Very Early Stage HCC
Moderator: Morris Sherman, MD, PhD
2. Antifibrotic Therapy – Translation into the Clinic
Moderators: Scott L. Friedman MD and Detlef Schuppan MD, PhD
3. Recent Advances in the Management of Minimal and
Overt Hepatic Encephalopathy – Are We There Yet?
Moderators: Jasmohan Bajaj, MD and Kevin D. Mullen, MD | |
|
| |
|